EPO has been reported to correct insulin resistance in patients on hemodialysis (Mak, 1998; Spaia et al., 2000), but studies in healthy human volunteers have shown no effect of a single dose (Christensen et al., 2012) or 10 weeks (Christensen et al., 2013) of EPO injections on insulin sensitivity. Here, INS is linked to Insulin resistance.